Pick a gene
Every map uses the same seven node types: gene and protein, phenotype, therapy, trial and study, biomarker and outcome measure, registry and biobank, and organization, center, or sponsor.
What the sources report across genes
Statements about what published sources and registry records report, assembled by reading across the gene maps. Each names who reported it, in which genes, and with what numbers where the source gives them. Method and inclusion rules follow below.
How these observations were made
How to read a map
Node types
Entry points
Each map opens on everything. The three entry points filter it to the node types most relevant to a newly diagnosed family, a drug developer, or a researcher and clinician.
Node labels
The small grey line under each node names its status: the stage a therapy has reached, a trial's phase and registry number, the type of measure, or the kind of data asset. The full record is in the panel beside the map.
What connects these genes
Two kinds of connection. Functional groups reported in the literature, where genes share a mechanism, a diagnostic assay, or a co-expression module. And resources counted from the maps themselves: the therapies, sponsors, platforms, centers, organizations, and measures recorded for more than one gene. Click any gene to open its map.
The connection map
Every mapped gene and everything it shares with another gene, in one graph. Circles are genes, coloured by functional group. Diamonds are shared resources: therapies, sponsors, platforms, centers, organizations, and measures. A line means that gene uses that resource. Click anything to see what it touches.
Functional groups from the literature
Every gene mapped here falls into at least one group. Genes can sit in more than one.
Resources already shared across genes
Computed from the maps and the landscape review, sorted by how many genes each reaches.